From bench to bedside: an interdisciplinary journey through the gut-lung axis with insights into lung cancer and immunotherapy

Front Immunol. 2024 Sep 5:15:1434804. doi: 10.3389/fimmu.2024.1434804. eCollection 2024.

Abstract

This comprehensive review undertakes a multidisciplinary exploration of the gut-lung axis, from the foundational aspects of anatomy, embryology, and histology, through the functional dynamics of pathophysiology, to implications for clinical science. The gut-lung axis, a bidirectional communication pathway, is central to understanding the interconnectedness of the gastrointestinal- and respiratory systems, both of which share embryological origins and engage in a continuous immunological crosstalk to maintain homeostasis and defend against external noxa. An essential component of this axis is the mucosa-associated lymphoid tissue system (MALT), which orchestrates immune responses across these distant sites. The review delves into the role of the gut microbiome in modulating these interactions, highlighting how microbial dysbiosis and increased gut permeability ("leaky gut") can precipitate systemic inflammation and exacerbate respiratory conditions. Moreover, we thoroughly present the implication of the axis in oncological practice, particularly in lung cancer development and response to cancer immunotherapies. Our work seeks not only to synthesize current knowledge across the spectrum of science related to the gut-lung axis but also to inspire future interdisciplinary research that bridges gaps between basic science and clinical application. Our ultimate goal was to underscore the importance of a holistic understanding of the gut-lung axis, advocating for an integrated approach to unravel its complexities in human health and disease.

Keywords: gut microbiome; gut permeability; gut-lung axis; immunotherapy; lung cancer; mucosal immunity.

Publication types

  • Review

MeSH terms

  • Animals
  • Dysbiosis / immunology
  • Gastrointestinal Microbiome* / immunology
  • Humans
  • Immunotherapy* / methods
  • Lung / immunology
  • Lung Neoplasms* / immunology
  • Lung Neoplasms* / therapy
  • Translational Research, Biomedical

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. DD was supported by the New National Excellence Program of the Ministry for Innovation and Technology of Hungary (UNKP-23-5), and by the Bolyai Research Scholarship of the Hungarian Academy of Sciences. DD also acknowledges funding from the Hungarian National Research, Development and Innovation Office (OTKA-PD, #142287). ZL acknowledges funding from the Hungarian National Research, Development and Innovation Office (OTKA-FK, #146775). NN was funded by Hungarian Science Foundation NKFI grant program, grant number K-138664, and by Research Excellence Program of the Hungarian National Research, Development and Innovation Office, within the framework of the TKP2021-EGA-25 thematic program of Semmelweis University.